Aktieanalys

Guard Therapeutics: Data collection in phase IIb study POINTER completed - Redeye

{newsItem.title}

Redeye Publicerad: I förrgår 09:03

Guard Therapeutics

Redeye briefly comments on Guard announcing that the data collection for the phase IIb study POINTER has been completed.

Länk till analysen i sin helhet: https://www.redeye.se/research/1127474/guard-therapeutics-data-collection-in-phase-iib-study-pointer-completed?utm_source=finwire&utm_medium=RSS

Nyheter om Guard Therapeutics

Läses av andra just nu

Om aktien Guard Therapeutics

Senaste nytt